CRISPR Therapeutics AG Quarterly Common Stock, Par or Stated Value Per Share in USD/shares from Q4 2021 to Q1 2024

Taxonomy & unit: us-gaap: CHF/shares and USD/shares
Description: Face amount or stated value per share of common stock.
Summary: CRISPR Therapeutics AG quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2021 to Q1 2024.
CRISPR Therapeutics AG Common Stock, Par or Stated Value Per Share for the quarter ending February 29, 2024 was 71.5 USD/shares.

Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)

Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$71.50^*	+$71.50		Feb 29, 2024	10-K	2025-02-11
Q2 2023	$0.03	$0	0%	Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$0.03	$0	0%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$0.03	$0	0%	Dec 31, 2022	10-Q	2023-08-07
Q3 2022	$0.03			Sep 30, 2022	10-Q	2022-11-01
Q2 2022	$0.03			Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$0.03			Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$0.03			Dec 31, 2021	10-Q	2022-11-01

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.